Follow

Brain+ A/S

Nasdaq First North GM Copenhagen (Denmark)

Brain+ develops Digital Therapeutics for Alzheimer’s and dementia, presenting a unique opportunity to invest in a growing megatrend at the frontier of health care digitalisation.
Go to market

Sector:
HEALTH CARE
>
Healthcare
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
BRAINP
DK0061670205
Nasdaq First North GM Copenhagen
Denmark (DK)
Details of share in Brain+ A/S with ticker BRAINP
Status
Active
Amount of instruments
11 815 912
Currency
DKK
First trading date
07 Oct 2021
Type
Ticker
ISIN
Market
OPTION
BRAINPW
DK0061670551
Nasdaq First North GM Copenhagen
Denmark (DK)
Details of option in Brain+ A/S with ticker BRAINPW
Status
Active
Amount of instruments
Currency
DKK
First trading date
07 Oct 2021
Terms
One (1) Unit consists of one (1) share and one (1) free of charge warrant. One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to 70 percent of the volume weighted average trading price during the period 10 days prior the exercise period begins.
Exercise
Sign in to buy
People
Kim Baden-Kristensen
CEO
Lars Terney
Chairman of the board
Jonas Nilsen
Board member
Hanne Leth Hillman
Board member
Kim Arvid Nielsen
Board member
Company Details
Sector
HEALTH CARE

Address
Købmagergade 53, 3
Zip code
DK-1150
City/district
Copenhagen
Country
Denmark (DK)
Phones
Registration number
36439440
LEI code
9845007708709CEGD845
First trade date
07 Oct 2021
Registration date
19 Nov 2014
Short name
Brain+

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More